Related by context. Frequent words. (Click for all words.) 72 Pivotal Phase 72 PRECiSE 68 HCV genotype 1 68 Phase 2a trial 68 placebo controlled trials 68 phase IIa 68 placebo controlled studies 68 SCH # 68 phase IIb 68 Phase 2b study 68 placebo controlled clinical 68 relapsed refractory multiple myeloma 68 nab paclitaxel 68 sustained virologic response 67 active comparator 67 peginterferon alfa 2b 67 nitazoxanide 66 glatiramer acetate 66 Pivotal Phase III 66 double blinded placebo 66 Amrubicin 66 Phase 1b trial 66 vicriviroc 66 Clinical Trial Results 66 Pivotal Trial 66 HGS ETR1 66 subgroup analyzes 66 peginterferon 65 chronic HCV infection 65 mg kg dose 65 Phase Ib 65 HCV infected 65 tocilizumab 65 axitinib 65 Chronic Hepatitis C 65 dose cohorts 65 interferon alfa 65 events SAEs 65 prospective observational 65 randomized Phase III 65 multicenter randomized 65 Solid Tumors 65 Phase III Clinical Trial 65 BMS # 65 PEG Interferon lambda 65 Phase 1b 64 Phase IIa trial 64 peg IFN 64 HER2 positive metastatic breast 64 dose escalation trial 64 Phase 2b trial 64 Alemtuzumab 64 blinded placebo controlled 64 TORISEL 64 Phase III Trial 64 NOXAFIL 64 dose regimens 64 Phase 2a clinical 64 FOLFIRI 64 chronic HCV 64 Arch Neurol 64 J Clin Oncol 64 BAY #-# 64 TMC# [001] 63 dacarbazine 63 LY# [003] 63 multicenter clinical 63 randomized placebo controlled 63 multicenter randomized double 63 mcg dose 63 multicentre 63 evaluable patients 63 aflibercept 63 Initiates Phase 63 entecavir 63 neoadjuvant 63 metastatic renal cell carcinoma 63 peginterferon alfa 2a 63 randomized Phase 63 Phase Ia 63 plus ribavirin 63 Phase 1b clinical 63 Apixaban 63 virologic failure 63 sunitinib 63 CRx 63 TELCYTA 63 ATTRACT 63 castration resistant prostate cancer 63 Irinotecan 63 Phase III randomized 63 XELOX 63 ocrelizumab 63 decitabine 63 ADXS# 63 refractory multiple myeloma 63 placebo controlled randomized 63 placebo controlled 63 hepatitis C HCV 63 Amigal 63 multicenter